References
- Shelton R C, Tollefson G D, Tohen M, et al. A novel augmentation strategy for treating resistant major depression. American Journal of Psychiatry 2001; 158: 131–134
- Corya S A, Andersen S W, Detke H C, et al. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study. Journal of Clinical Psychiatry 2003; 64: 1349–1356
- Li X M, Perry K W, Wong D T, Bymaster F P. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology 1998; 136: 153–161